Hypofractionated Radiotherapy and Prostate Cancer

Men who are diagnosed with prostate cancer are very likely to find that some form of radiation treatment is recommended to help ensure this disease is effectively tackled. While radiation can present with the potential for side effects, this option is one of the most effective for killing off cancer cells. Some forms of radiation therapy, however, may increase the risks for side effects. Researchers are finding, in fact, that hypofractionated radiotherapy may present with a greater risk of late toxicity than conventional radiation treatment methods.

Hyopfractionated radiotherapy is a form of radiation that is divided into much larger doses. The overall treatment lasts over a much shorter period than standard radiation therapy. While hypofractionated radiation can cut overall treatment time dramatically, but researchers are finding it is not without a chance for increased risks. The increase is especially related to late gastrointestinal toxicity, researchers found.

Men who are diagnosed with prostate cancer will find that hypofractionated radiotherapy is not their only treatment option. Traditional external beam radiation, brachytherapy and proton therapy may also offer positive results in regard to fighting the disease. While these forms of radiation do also have side effect risks they may be lower than the hypofractionated option.

Prostate cancer affects an estimated 180,000 American men each year. About 26,000 men die from the disease annually. The best treatment method will depend on a number of factors, including the stage of cancer and the aggressiveness. Men who do receive a positive diagnosis of prostate cancer are urged to discuss all treatment options with their healthcare providers. It is important for men to understand the potential benefits and risks of all treatment recommendations. For some, the faster, more aggressive treatment associated with hypofractionated radiotherapy might be worth the elevated side effect risks.

Since all men are at risk for prostate cancer it is recommended that men discuss their personal risks with their healthcare providers. Routine screening can be critical for detecting this disease in its earliest, most treatable stage.